Theranexus

📍 Lyon, France🗓 Founded 2013👥 24 employees💰 Last funded Dec 2018
Biotechnology Research🌐 theranexus.com
Website LinkedIn
Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
1
Denmark
1
Frequently asked questions
Who invested in Theranexus?
Theranexus has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Theranexus last raise funding?
The most recent investment in Theranexus recorded on gritt.io was in December 2018.
When was Theranexus founded?
Theranexus was founded in 2013.
What industry is Theranexus in?
Theranexus operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Theranexus based?
Theranexus is headquartered in Lyon, France.